全文获取类型
收费全文 | 3839篇 |
免费 | 137篇 |
国内免费 | 30篇 |
专业分类
耳鼻咽喉 | 176篇 |
儿科学 | 80篇 |
妇产科学 | 107篇 |
基础医学 | 547篇 |
口腔科学 | 30篇 |
临床医学 | 355篇 |
内科学 | 1063篇 |
皮肤病学 | 12篇 |
神经病学 | 248篇 |
特种医学 | 118篇 |
外科学 | 439篇 |
综合类 | 29篇 |
一般理论 | 3篇 |
预防医学 | 182篇 |
眼科学 | 73篇 |
药学 | 292篇 |
中国医学 | 2篇 |
肿瘤学 | 250篇 |
出版年
2024年 | 4篇 |
2023年 | 29篇 |
2022年 | 156篇 |
2021年 | 245篇 |
2020年 | 65篇 |
2019年 | 105篇 |
2018年 | 134篇 |
2017年 | 82篇 |
2016年 | 99篇 |
2015年 | 113篇 |
2014年 | 163篇 |
2013年 | 210篇 |
2012年 | 316篇 |
2011年 | 349篇 |
2010年 | 167篇 |
2009年 | 109篇 |
2008年 | 235篇 |
2007年 | 239篇 |
2006年 | 263篇 |
2005年 | 221篇 |
2004年 | 225篇 |
2003年 | 188篇 |
2002年 | 136篇 |
2001年 | 13篇 |
2000年 | 8篇 |
1999年 | 9篇 |
1998年 | 14篇 |
1997年 | 10篇 |
1996年 | 10篇 |
1995年 | 9篇 |
1994年 | 5篇 |
1993年 | 6篇 |
1992年 | 6篇 |
1991年 | 4篇 |
1990年 | 13篇 |
1989年 | 8篇 |
1988年 | 6篇 |
1987年 | 6篇 |
1985年 | 2篇 |
1982年 | 1篇 |
1981年 | 3篇 |
1980年 | 2篇 |
1979年 | 2篇 |
1978年 | 2篇 |
1977年 | 1篇 |
1976年 | 1篇 |
1975年 | 4篇 |
1971年 | 1篇 |
1967年 | 3篇 |
1966年 | 2篇 |
排序方式: 共有4006条查询结果,搜索用时 15 毫秒
111.
112.
113.
Chua JJ Butkevich E Worseck JM Kittelmann M Grønborg M Behrmann E Stelzl U Pavlos NJ Lalowski MM Eimer S Wanker EE Klopfenstein DR Jahn R 《Proceedings of the National Academy of Sciences of the United States of America》2012,109(15):5862-5867
Presynaptic nerve terminals are formed from preassembled vesicles that are delivered to the prospective synapse by kinesin-mediated axonal transport. However, precisely how the various cargoes are linked to the motor proteins remains unclear. Here, we report a transport complex linking syntaxin 1a (Stx) and Munc18, two proteins functioning in synaptic vesicle exocytosis at the presynaptic plasma membrane, to the motor protein Kinesin-1 via the kinesin adaptor FEZ1. Mutation of the FEZ1 ortholog UNC-76 in Caenorhabditis elegans causes defects in the axonal transport of Stx. We also show that binding of FEZ1 to Kinesin-1 and Munc18 is regulated by phosphorylation, with a conserved site (serine 58) being essential for binding. When expressed in C. elegans, wild-type but not phosphorylation-deficient FEZ1 (S58A) restored axonal transport of Stx. We conclude that FEZ1 operates as a kinesin adaptor for the transport of Stx, with cargo loading and unloading being regulated by protein kinases. 相似文献
114.
115.
Charchar FJ Bloomer LD Barnes TA Cowley MJ Nelson CP Wang Y Denniff M Debiec R Christofidou P Nankervis S Dominiczak AF Bani-Mustafa A Balmforth AJ Hall AS Erdmann J Cambien F Deloukas P Hengstenberg C Packard C Schunkert H Ouwehand WH Ford I Goodall AH Jobling MA Samani NJ Tomaszewski M 《Lancet》2012,379(9819):915-922
116.
117.
118.
AA Toor KK Payne HM Chung RT Sabo AF Hazlett M Kmieciak K Sanford DC Williams WB Clark CH Roberts JM McCarty MH Manjili 《British journal of haematology》2012,158(6):700-711
Patients with multiple myeloma (MM) undergoing high dose therapy and autologous stem cell transplantation (SCT) remain at risk for disease progression. Induction of the expression of highly immunogenic cancer testis antigens (CTA) in malignant plasma cells in MM patients may trigger a protective immune response following SCT. We initiated a phase II clinical trial of the DNA hypomethylating agent, azacitidine (Aza) administered sequentially with lenalidomide (Rev) in patients with MM. Three cycles of Aza and Rev were administered and autologous lymphocytes were collected following the 2nd and 3rd cycles of Aza‐Rev and cryopreserved. Subsequent stem cell mobilization was followed by high‐dose melphalan and SCT. Autologous lymphocyte infusion (ALI) was performed in the second month following transplantation. Fourteen patients have completed the investigational therapy; autologous lymphocytes were collected from all of the patients. Thirteen patients have successfully completed SCT and 11 have undergone ALI. Six patients tested have demonstrated CTA up‐regulation in either unfractionated bone marrow (n = 4) or CD138+ cells (n = 2). CTA (CTAG1B)‐specific T cell response has been observed in all three patients tested and persists following SCT. Epigenetic induction of an adaptive immune response to cancer testis antigens is safe and feasible in MM patients undergoing SCT. 相似文献
119.
120.
Bielecka-Dabrowa A Mikhailidis DP Jones L Rysz J Aronow WS Banach M 《International journal of cardiology》2012,158(1):12-17
Maintenance of normal potassium (K(+)) homeostasis has become an increasingly important limiting factor in the therapy of heart failure (HF). With the application of loop diuretics and digoxin, hypokalemia has become a frequent and feared side effect of treatment. Low serum K(+) in HF may be also a marker of increased neurohormonal activity and disease progression. To gain the maximum benefit from treatment, we need to individualize drug use and carefully monitor electrolytes. Symptomatic HF patients (New York Heart Association class III-IV) should be prescribed the lowest dose of diuretic necessary to maintain euvolemia. Mild hypokalemia may be corrected by the use of aldosterone receptor antagonists such as spironolactone or eplerenone. However, a more severe hypokalemia should preferably be corrected using K(+) supplement. Serum K levels should be frequently checked and maintained between 4.0 and 5.5 mEq/l (mmol/l). 相似文献